Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 81 entries
View as:

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06390241 Org: User:
Start: 06/19/24 End: 01/30/25 Due: 01/30/26

National Database of Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06367491 Org: User:
Start: 10/08/13 End: 01/01/30 Due: 01/01/31

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.

Phase: N/A Priority: Normal
NCT ID: NCT03381326 Org: User:
Start: 12/15/14 End: 12/31/23 Due: 12/31/24

Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2

Phase: N/A Priority: Normal
NCT ID: NCT01884961 Org: User:
Start: 07/09/12 End: 01/31/25 Due: 01/31/26

Participatory Research for Fine-tuning of a 2.0 System to Optimise Home Management of Oral Cancer Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT02921724 Org: User:
Start: 01/27/16 End: 05/31/21 Due: 05/31/22

CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas

Phase: N/A Priority: Normal
NCT ID: NCT03387592 Org: User:
Start: 03/06/17 End: 02/28/22 Due: 02/28/23

Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02919644 Org: User:
Start: 12/02/16 End: 12/31/31 Due: 12/31/32

Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)

Phase: N/A Priority: Normal
NCT ID: NCT01031030 Org: User:
Start: 11/30/97 End: - Due: -

Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02035072 Org: User:
Start: 11/30/10 End: 12/31/16 Due: 12/31/17

Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA

Phase: N/A Priority: Normal
NCT ID: NCT03982641 Org: User:
Start: 04/16/19 End: 12/31/20 Due: 12/31/21

CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

Phase: N/A Priority: Normal
NCT ID: NCT03227328 Org: User:
Start: 08/02/17 End: 07/01/22 Due: 07/01/23

Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06909968 Org: User:
Start: 12/14/20 End: 09/30/25 Due: 09/30/26

Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02489604 Org: User:
Start: 12/31/13 End: 01/31/24 Due: 01/31/25

GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05861336 Org: User:
Start: 06/14/23 End: 12/23/24 Due: 12/23/25

Sequential Treatment Strategy for Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01878422 Org: User:
Start: 11/30/07 End: 06/11/16 Due: 06/11/17

Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL)

Phase: N/A Priority: Normal
NCT ID: NCT05434208 Org: User:
Start: 09/30/22 End: 09/30/25 Due: 09/30/26

ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate

Phase: N/A Priority: Normal
NCT ID: NCT03898128 Org: User:
Start: 11/27/19 End: 09/30/21 Due: 09/30/22

A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02488564 Org: User:
Start: 12/17/14 End: 03/17/20 Due: 03/17/21

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.

Phase: N/A Priority: Normal
NCT ID: NCT03411408 Org: User:
Start: 02/22/18 End: 05/31/24 Due: 05/31/25

Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

Phase: N/A Priority: Normal
NCT ID: NCT04826458 Org: User:
Start: 05/04/21 End: 05/31/23 Due: 05/31/24

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)

Phase: N/A Priority: Normal
NCT ID: NCT02000375 Org: User:
Start: 03/31/13 End: 02/29/16 Due: 02/28/17

Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

Phase: N/A Priority: Normal
NCT ID: NCT04345315 Org: User:
Start: 03/27/20 End: 03/31/22 Due: 03/31/23

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06136065 Org: User:
Start: 08/21/23 End: 09/30/25 Due: 09/30/26

Prehabilitation in Geriatric Patients With Colorectal Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT05851235 Org: User:
Start: 03/22/23 End: 03/31/24 Due: 03/31/25

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03789981 Org: User:
Start: 07/19/19 End: 12/31/25 Due: 12/31/26